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Abstract Antimicrobial peptides (AMPs) are host-encoded antibiotics that combat invading
microorganisms. These short, cationic peptides have been implicated in many biological processes,
primarily involving innate immunity. In vitro studies have shown AMPs kill bacteria and fungi at
physiological concentrations, but little validation has been done in vivo. We utilized CRISPR gene
editing to delete all known immune-inducible AMPs of Drosophila, namely: 4 Attacins, 4 Cecropins,
2 Diptericins, Drosocin, Drosomycin, Metchnikowin and Defensin. Using individual and multiple
knockouts, including flies lacking all 14 AMP genes, we characterize the in vivo function of
individual and groups of AMPs against diverse bacterial and fungal pathogens. We found that
Drosophila AMPs act primarily against Gram-negative bacteria and fungi, contributing either
additively or synergistically. We also describe remarkable specificity wherein certain AMPs
contribute the bulk of microbicidal activity against specific pathogens, providing functional
demonstrations of highly specific AMP-pathogen interactions in an in vivo setting.
DOI: https://doi.org/10.7554/eLife.44341.001
Introduction
While innate immune mechanisms were neglected during the decades where adaptive immunity cap-
tured most of the attention, they have become central to our understanding of immunology. Recent
emphasis on innate immunity has, however, mostly focused on the first two phases of the immune
response: microbial recognition and associated downstream signaling pathways. In contrast, how
innate immune effectors individually or collectively contribute to host resistance has not been investi-
gated to the same extent. The existence of multiple effectors that redundantly contribute to host
resistance has hampered their functional characterization by genetic approaches (Lemaitre and
Hoffmann, 2007). The single mutation methodology that still prevails today has obvious limits in the
study of immune effectors, which often belong to large gene families. As such, our current under-
standing of the logic underlying the roles of immune effectors is only poorly defined. As a conse-
quence, the key parameters that influence host survival associated with a successful immune
response are not well characterized. In this paper, we harnessed the power of the CRISPR gene edit-
ing approach to study the function of Drosophila antimicrobial peptides in host defence both indi-
vidually and collectively.
Antimicrobial peptides (AMPs) are small, cationic, usually amphipathic peptides that contribute to
innate immune defence in plants and animals (Imler and Bulet, 2005; Guanı´-Guerra et al., 2010;
Rolff and Schmid-Hempel, 2016). They display potent antimicrobial activity in vitro by disrupting
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negatively charged microbial membranes, but AMPs can also target specific microbial
processes (Park et al., 1998; Kragol et al., 2001; Rahnamaeian et al., 2015). Their expression is
induced to very high levels upon challenge to provide microbicidal concentrations in the mM range.
Numerous studies have revealed unique roles that AMPs may play in host physiology including anti-
tumor activity (Suttmann et al., 2008; Kuroda et al., 2015; Araki et al., 2018; Parvy et al., 2019),
inflammation in aging (Cao et al., 2013; Kounatidis et al., 2017; E et al., 2018), involvement in
memory (Bozler et al., 2017; Barajas-Azpeleta et al., 2018), mammalian immune
signaling (van Wetering et al., 2002; Tjabringa et al., 2003), wound-healing (Tokumaru et al.,
2005; Chung et al., 2017), regulation of the host microbiota (Login et al., 2011; Mergaert et al.,
2017), tolerance to oxidative stress (Zhao et al., 2011; Zheng et al., 2007), and of course microbici-
dal activity (Imler and Bulet, 2005; Wimley, 2010). The fact that AMP genes are immune inducible
and expressed at high levels has led to the common assumption they play a vital role in the innate
immune response. However, little is known in most cases about how AMPs individually or
collectively contribute to animal host defence. In vivo functional analysis of AMPs has been ham-
pered by the sheer number and small size of these genes, making them difficult to mutate with tradi-
tional genetic tools (but e.g. see Hoeckendorf et al., 2012).
Since the first animal AMPs were discovered in silk moths (Steiner et al., 1981), insects and par-
ticularly Drosophila melanogaster have emerged as a powerful model for characterizing their func-
tion. There are currently seven well-characterized families of inducible AMPs in D. melanogaster, but
we note that many genes encoding small peptides are strongly upregulated upon infection and are
awaiting description (De Gregorio et al., 2002). The activities of the seven known AMP families of
Drosophila have been determined either in vitro by using peptides directly purified from flies or pro-
duced in heterologous systems, or deduced by comparison with homologous peptides isolated in
other insect species: Drosomycin and Metchnikowin show antifungal activity (Fehlbaum et al., 1994;
Levashina et al., 1995); Cecropins (four inducible genes) and Defensin have both antibacterial and
some antifungal activities (Hultmark et al., 1980; Ekengren and Hultmark, 1999; Cociancich et al.,
1993; Tzou et al., 2002); and Drosocin, Attacins (four genes) and Diptericins (two genes) primarily
eLife digest All animals – from humans to mice, jellyfish to fruit flies – are armed with an
immune system to defend against infections. The immune system’s first line of defence often
involves a group of short proteins called antimicrobial peptides. These proteins are found anywhere
that germs and microbes come into contact with the body, including the skin, eyes and lungs. In
many cases, it is unclear how individual antimicrobial peptides work. For example, which germs are
they most effective against? Do they work alone, or in a mixture of other antimicrobial peptides?
To learn more about a protein, scientists can often delete the gene that encodes it and observe
what happens. Antimicrobial peptides, however, are small proteins encoded by a large number of
very short genes, which makes them difficult to target with most genetic tools. Fortunately, gene
editing via the CRISPR/Cas9 system can overcome many of the limitations of more traditional
methods; this allowed Hanson et al. to systematically remove the antimicrobial peptide genes from
fruit flies to explore how these proteins work.
In the experiments, all 14 antimicrobial peptide genes known from fruit flies were removed, and
the flies were then infected with a variety of bacteria and fungi. Hanson et al. found that the
antimicrobial peptides were effective against many bacteria, but unexpectedly they were far more
important for controlling one general kind of bacterial infection, but not another kind. Further
experiments showed that some of these proteins work alone, targeting only a particular species of
microbe. This finding suggested that animals might fight infections by very specific bacteria with a
very specific antimicrobial peptide rather than with a mixture.
By understanding how antimicrobial peptides work in more detail, scientists can learn what types
of microbes they are most effective against. In the future, this information may eventually lead to the
development of new types of antibiotics and better management of diseases that affect important
insects, like bumblebees.
DOI: https://doi.org/10.7554/eLife.44341.002
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exhibit antibacterial activity (Kragol et al., 2001; Asling et al., 1995; Cudic et al., 1999;
Hedengren et al., 2000; Bulet et al., 1996). In Drosophila, these AMPs are produced either locally
at various surface epithelia in contact with environmental microbes (Tzou et al., 2000; Basset et al.,
2000; Gendrin et al., 2009), or secreted systemically into the hemolymph, the insect blood. During
systemic infection, these 14 antimicrobial peptides are strongly induced in the fat body, an organ
analogous to the mammalian liver.
The systemic production of AMPs is regulated at the transcriptional level by two NF-kB pathways,
the Toll and Imd pathways, which are activated by different classes of microbes. The Toll pathway is
predominantly responsive to Gram-positive bacteria and fungi, and accordingly plays a major role in
defence against these microbes. In contrast, the Imd pathway is activated by Gram-negative bacteria
and a subset of Gram-positive bacteria with DAP-type peptidoglycan, and mutations affecting this
pathway cause profound susceptibility to Gram-negative bacteria (De Gregorio et al., 2002;
Lemaitre et al., 1997). However, the expression pattern of AMP genes is complex as each gene is
expressed with different kinetics and can often receive transcriptional input from both
pathways (De Gregorio et al., 2002; Leulier et al., 2000). This ranges from Diptericin, which is
tightly regulated by the Imd pathway, to Drosomycin, whose expression is mostly regulated by the
Toll pathway (Lemaitre et al., 1997), except at surface epithelia where Drosomycin is under the con-
trol of Imd signaling (Ferrandon et al., 1998; Tzou et al., 2000). While a critical role of AMPs in
Drosophila host defence is supported by transgenic flies overexpressing a single AMP (Tzou et al.,
2002), the specific contributions of each of these AMPs has not been tested. Indeed loss-of-function
mutants for most AMP genes were not previously available due to their small size, making them diffi-
cult to mutate before the advent of CRISPR/Cas9 technology. Despite this, the great susceptibility
to infection of mutants with defective Toll and Imd pathways is commonly attributed to the loss of
the AMPs they regulate, though these pathways control hundreds of genes awaiting
characterization (De Gregorio et al., 2002). Strikingly, Clemmons et al. (2015) recently reported
that flies lacking a set of uncharacterized Toll-responsive peptides (named Bomanins) succumb to
infection by Gram-positive bacteria and fungi at rates similar to Toll-deficient
mutants (Clemmons et al., 2015). This provocatively suggests that Bomanins, and not AMPs, might
be the predominant effectors downstream of the Toll pathway; yet synthesized Bomanins do not dis-
play antimicrobial activity in vitro (Lindsay et al., 2018). Thus, while today the fly represents one of
the best-characterized animal immune systems, the contribution of AMPs as immune effectors is
poorly defined as we still do not understand why Toll and Imd pathway mutants succumb to
infection.
In this paper, we took advantage of recent gene editing technologies to delete each of the
known immune inducible AMP genes of Drosophila. Using single and multiple knockouts, as well as
a variety of bacterial and fungal pathogens, we have characterized the in vivo function of individual
and groups of antimicrobial peptides. We reveal that AMPs can play highly specific roles in defence,
being vital for surviving certain infections yet dispensable against others. We highlight key interac-
tions amongst immune effectors and pathogens and reveal to what extent these defence peptides
act in concert or alone.
Results
Generation and characterization of AMP mutants
We generated null mutants for 14 Drosophila antimicrobial peptide genes that are induced upon
systemic infection. These include five single gene mutations affecting Defensin (DefSK3), Attacin C
(AttCMi), Metchnikowin (MtkR1), Attacin D (AttDSK1) and Drosomycin (DrsR1), respectively, and three
small deletions removing both Diptericins DptA and DptB (DptSK1), the four Cecropins CecA1,
CecA2, CecB, and CecC (CecSK6) and the gene cluster containing Drosocin, and Attacins AttA and
AttB (Dro-AttABSK2). All mutations/deletions were made using the CRISPR editing approach with the
exception of Attacin C, which was disrupted by insertion of a Minos transposable
element (Bellen et al., 2011), and the Drosomycin and Metchnikowin deletions generated by homol-
ogous recombination (Figure 1A and Figure 1—figure supplement 1). To disentangle the role of
Drosocin and AttA/AttB in the Dro-AttABSK2 deletion, we also generated an individual Drosocin
mutant (DroSK4); for complete information, see Figure 1—figure supplement 1. We then isogenized
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Figure 1. Description of AMP mutants. (A) Chromosomal locations of AMP genes that were deleted. Each mutation is color-coded with the mutagenic
agent: black, a Minos insertion or homologous recombination, red, CRISPR-CAS9-mediated deletion, and blue CRISPR CAS9 mediated indel causing a
nonsense peptide. (B) A representative MALDI-TOF analysis of hemolymph samples from immune-challenged (1:1 E. coli and M. luteus at OD600 = 200)
iso w1118 and DAMPs flies as described in Uttenweiler-Joseph et al. (1998). No AMP-derived products were detected in the hemolymph samples of
Figure 1 continued on next page
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these mutations for at least seven generations into the w1118 DrosDel isogenic genetic
background (Ryder et al., 2004) (iso w1118). Then, we recombined these eight independent muta-
tions into a background lacking these 14 inducible AMPs referred to as ‘DAMPs.’ DAMPs flies were
viable and showed no morphological defects. To confirm the absence of AMPs in our DAMPs back-
ground, we performed a MALDI-TOF analysis of hemolymph from both unchallenged and immune-
challenged flies infected by a mixture of Escherichia coli and Micrococcus luteus. This analysis
revealed the presence of peaks induced upon challenge corresponding to AMPs in wild-type but not
DAMPs flies. Importantly, it also confirmed that induction of most other immune-induced molecules
(IMs) (Uttenweiler-Joseph et al., 1998), was unaffected in DAMPs flies (Figure 1B). Of note, we
failed to observe two IMs, IM7 and IM21, in our DAMPs flies, suggesting that these unknown pepti-
des are secondary products of AMP genes. We further confirmed that Toll and Imd NF-kB signaling
pathways were intact in DAMPs flies by measuring the expression of target genes of these pathways
(Figure 1C–D). This demonstrates that Drosophila AMPs are not signaling molecules required for
Toll or Imd pathway activity. We also assessed the role of AMPs in the melanization response, wound
clotting, and hemocyte populations. After clean injury, DAMPs flies survive as wild-type (Figure 1—
figure supplement 2A). We found no defect in melanization (c2, p=0.34, Figure 1—figure supple-
ment 2B) as both adults and larvae strongly melanize the cuticle following clean injury (Figure 1—
figure supplement 2C). Furthermore, we visualized the rapid formation of clot fibers ex vivo using
the hanging drop assay and PNA staining (Scherfer et al., 2004) in hemolymph of both wild-type
and DAMPs larvae (Figure 1—figure supplement 2D). Hemocyte counting (i.e. crystal cells, FACS)
did not reveal any deficiency in hemocyte populations of DAMPs larvae (Figure 1—figure supple-
ment 2E,F, and not shown). Altogether, our study suggests that Drosophila AMPs are primarily
immune effectors, and not regulators of innate immunity.
AMPs are essential for combating Gram-negative bacterial infection
We used these DAMPs flies to explore the role that AMPs play in defence against pathogens during
systemic infection. We first focused our attention on Gram-negative bacterial infections, which are
combatted by Imd pathway-mediated defence in Drosophila (Lemaitre and Hoffmann, 2007). We
challenged wild-type and DAMPs flies with six different Gram-negative bacterial species, using inocu-
lation doses (given as OD600) selected such that at least some wild-type flies were killed. In our sur-
vival experiments, we also include Oregon R (OR-R) as an alternate wild-type for comparison, and
Relish mutants (RelE20) that lack a functional Imd response and are known to be very susceptible to
this class of bacteria (Hedengren et al., 1999) (Figure 2). Globally, DAMPs flies were extremely sus-
ceptible to all Gram-negative pathogens tested (Figure 2, light blue plots). The susceptibility of
AMP-deficient flies to Gram-negative bacteria largely mirrored that of RelE20 flies. For all Gram-neg-
ative infections tested, DAMPs flies show a higher bacterial count at 18 hr post-infection (hpi) indicat-
ing that AMPs actively inhibit bacterial growth, as expected of ‘antimicrobial peptides’ (Figure 2—
figure supplement 1A). Use of GFP-expressing bacteria show that bacterial growth in DAMPs flies
radiates from the wound site until spreading systemically (Figure 2—figure supplement 1B,C). Col-
lectively, the use of AMP-deficient flies reveals that AMPs are major players in resistance to Gram-
negative bacteria, and likely constitute an essential component of the Imd pathway’s contribution
for survival against these germs.
Figure 1 continued
DAMPs flies. No signals for IM7, nor IM21 were observed in the hemolymph samples of DAMPs mutants suggesting that these uncharacterized immune-
induced molecules are the products of AMP genes. The Imd pathway (C) and Toll pathway (D) are functional and respond to immune challenge in
DAMPs flies. We used alternate readouts to monitor the Toll and Imd pathways: pirk and PGRP-LB for Imd pathway and CG5791 (Bomanin) and IMPPP
for Toll signaling (De Gregorio et al., 2002; Hanson et al., 2016). UC = unchallenged, Inf = infected. hpi = hours post-infection. Expression
normalized with iso w1118-UC set to a value of 1.
DOI: https://doi.org/10.7554/eLife.44341.003
The following figure supplements are available for figure 1:
Figure supplement 1. Genetic description of mutations generated in this study.
DOI: https://doi.org/10.7554/eLife.44341.004
Figure supplement 2. DAMPs flies have otherwise wild-type immune reactions.
DOI: https://doi.org/10.7554/eLife.44341.005
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Figure 2. Survival of DAMPs flies to diverse microbial challenges. Control lines for survival experiments included two wild-types (w;Drosdel (iso w1118)
and Oregon R (OR-R) as an alternate wild-type), mutants for the Imd response (RelE20), mutants for Toll signaling (spzrm7), and mutants for Bomanins
(BomD55C). DAMPs flies are extremely susceptible to infection with Gram-negative bacteria (blue backgrounds). Unexpectedly, DAMPs flies were not
markedly susceptible to infection with Gram-positive bacteria (orange backgrounds), while BomD55C flies were extremely susceptible, often mirroring
Figure 2 continued on next page
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Bomanins and to a lesser extent AMPs contribute to resistance against
Gram-positive bacteria and fungi
Previous studies have shown that resistance to Gram-positive bacteria and fungi in Drosophila is
mostly mediated by the Toll pathway, although the Imd pathway also contributes to some
extent (Lemaitre et al., 1997; Leulier et al., 2000; Rutschmann et al., 2002; Tanji et al., 2007).
Moreover, a deletion removing ten uncharacterized Bomanins (BomD55C) induces a strong suscepti-
bility to both Gram-positive bacteria and fungi (Clemmons et al., 2015), suggesting that Bomanins
are major players downstream of Toll in the defence against these germs. This prompted us to
explore the role of antimicrobial peptides in defence against Gram-positive bacteria and fungi. In
these experiments, we additionally included spa¨tzle mutant flies (spzrm7) lacking Toll signaling as sus-
ceptible controls. We first challenged wild-type and DAMPs flies with two lysine-type (E. faecalis, S.
aureus) and two DAP-type (B. subtilis, L. innocua) peptidoglycan-containing Gram-positive bacterial
species. We observed that DAMPs flies display only weak or no increased susceptibility to infection
with these Gram-positive bacterial species, as DAMPs survival rates were closer to the wild-type than
to spzrm7 mutants lacking a functional Toll pathway (Figure 2, orange plots), with the exception of S.
aureus. Meanwhile, BomD55C mutants consistently phenocopied spzrm7 flies, confirming the impor-
tant contribution of these peptides in defence against Gram-positive bacteria (Clemmons et al.,
2015).
Next, we monitored the survival of DAMPs to the yeast Candida albicans, the opportunistic fun-
gus Aspergillus fumigatus and two entomopathogenic fungi, Beauveria bassiana, and Metarhizium
anisopliae. For the latter two, we used a natural mode of infection by spreading spores on the
cuticle (Lemaitre et al., 1997). DAMPs flies were more susceptible to fungal infections with B. bassi-
ana, A. fumigatus, and C. albicans, but not M. anisopliae (Figure 2, yellow plots). In all instances,
BomD55C mutants were as or more susceptible to fungal infection than DAMPs flies, approaching
Toll-deficient mutant levels. Collectively, our data demonstrate that AMPs are major immune effec-
tors in defence against Gram-negative bacteria and have a less essential role in defence against bac-
teria and fungi.
A combinatory approach to explore AMP interactions
The impact of the DAMPs deletion on survival could be due to the action of certain AMPs having a
specific effect, or more likely due to the combinatory action of co-expressed AMPs. Indeed, cooper-
ation of AMPs to potentiate their microbicidal activity has been suggested by numerous in vitro
approaches (Rahnamaeian et al., 2015; Yu et al., 2016; Mohan et al., 2014), but rarely in an in vivo
context (Zanchi et al., 2017). Having shown that AMPs as a whole significantly contribute to fly
defence, we next explored the contribution of individual peptides to this effect. To tackle this ques-
tion in a systematic manner, we performed survival analyses using fly lines lacking one or several
AMPs, focusing on pathogens with a range of virulence that we previously showed to be sensitive to
the action of AMPs. This includes the yeast C. albicans and the Gram-negative bacterial species P.
burhodogranariea, P. rettgeri, Ecc15, and E. cloacae. Given eight independent AMP mutations, over
250 combinations of mutants are possible, making a systematic analysis of AMP interactions a logisti-
cal nightmare. Therefore, we designed an approach that would allow us to characterize their contri-
butions to defence by deleting groups of AMPs. To this end, we generated three groups of
Figure 2 continued
spzrm7 mutants. This pattern of BomD55C susceptibility held true for fungal infections (yellow backgrounds). DAMPs flies are somewhat susceptible to
fungal infections, but the severity shifts with different fungi. Pellet densities are reported for all systemic infections in OD at 600 nm. p-Values are given
for DAMPs flies compared to iso w1118 using a Cox-proportional hazards model. N = total number of flies in experiments. A full description of p-values
relative to iso w1118 can be found in Figure 2—source data 1.
DOI: https://doi.org/10.7554/eLife.44341.006
The following source data and figure supplement are available for figure 2:
Source data 1. p-Values from Figure 2A relative to iso w1118.
DOI: https://doi.org/10.7554/eLife.44341.008
Figure supplement 1. DAMPs flies fail to suppress Gram-negative bacterial growth.
DOI: https://doi.org/10.7554/eLife.44341.007
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combined mutants: flies lacking the primarily antibacterial Defensin and Cecropins (Group A, mostly
regulated by the Imd pathway), flies lacking the antibacterial Proline-rich Drosocin, and the antibac-
terial Glycine-rich Diptericins and Attacins (Group B, regulated by the Imd pathway), and flies lacking
the two antifungal peptide genes Metchnikowin and Drosomycin (Group C, mostly regulated by the
Toll pathway). We then combined these three groups to generate flies lacking AMPs from groups A
and B (AB), A and C (AC), or B and C (BC). Finally, flies lacking all three groups are our DAMPs flies,
which are highly susceptible to a number of infections. By screening these seven genotypes as well
as individual mutants, we were able to assess potential interactions between AMPs of different
groups, as well as decipher the function of individual AMPs.
Drosomycin and metchnikowin additively contribute to defence against
the yeast C. albicans
We first applied this AMP-groups approach to infections with the relatively avirulent yeast C. albi-
cans. Previous studies have shown that Toll, but not Imd, contributes to defence against this
fungus (Gottar et al., 2006; Glittenberg et al., 2011). Thus, we suspected that the two antifungal
peptides, Drosomycin and Metchnikowin, could play a significant role in the susceptibility of DAMPs
flies to this yeast. Consistent with this, Group C flies lacking Metchnikowin and Drosomycin were
more susceptible to infection (p<0.001 relative to iso w1118) with a survival rate similar to DAMPs flies
(Figure 3A). Curiously, AC-deficient flies that also lack Cecropins and Defensin survived better than
Group-C-deficient flies (Log-Rank p=0.014). We have no explanation for this interaction, but this
could be due to i) a better canalization of the immune response by preventing the induction of inef-
fective AMPs, ii) complex biochemical interactions amongst the AMPs involved affecting either the
host or pathogen or iii) differences in genetic background generated by additional recombination.
We then investigated the individual contributions of Metchnikowin and Drosomycin to survival to C.
albicans. We found that both MtkR1 and DrsR1 individual mutants were somewhat susceptible to
infection, but notably only Mtk; Drs compound mutants reached DAMPs levels of susceptibility
(Figure 3B). This co-occurring loss of resistance appears to be primarily additive (Mutant, Cox Haz-
ard Ratio (HR), p-value: MtkR1, HR =+1.17, p=0.008; DrsR1, HR =+1.85, p<0.001; Mtk*Drs,
HR =  0.80, p=0.116). We observed that Group C deficient flies eventually succumb to uncontrolled
C. albicans growth by monitoring yeast titre, indicating that these AMPs indeed act by suppressing
yeast growth (Figure 3C).
In conclusion, our study provides an in vivo validation of the potent antifungal activities of Metch-
nikowin and Drosomycin (Fehlbaum et al., 1994; Levashina et al., 1995), and highlights a clear
example of additive cooperation of AMPs.
AMPs synergistically contribute to defence against P.
burhodogranariea
We next analyzed the contribution of AMPs in resistance to infection with the moderately virulent
Gram-negative bacterium P. burhodogranariea. We found that Group B mutants lacking Drosocin,
the two Diptericins, and the four Attacins, were as susceptible to infection as DAMPs flies
(Figure 4A), while flies lacking the antifungal peptides Drosomycin and Metchnikowin (Toll-regu-
lated, Group C) resisted the infection as wild-type. Flies lacking Defensin and the four Cecropins
(Group A) showed an intermediate susceptibility, but behave as wild-type in the additional absence
of Toll Group C peptides (Group AC). Thus, we again observed a better survival rate with the co-
occurring loss of Group A and C peptides (see possible explanation above). In this case, Group A
flies were susceptible while AC flies were not. Flies individually lacking Defensin or the four Cecro-
pins were weakly susceptible to P. burhodogranariea (p=0.022 and p=0.040, respectively); however,
the interaction term between Defensin and the Cecropins was not significant (DefSK3*CecSK6,
HR =  0.28, p=0.382), indicating the susceptibility of Group A flies arises from additive loss of resis-
tance (Figure 4—figure supplement 1A).
Following the observation that Group B flies were as susceptible as DAMPs flies, we sought to
better decipher the contribution of each Group B AMP to resistance to P. burhodogranariea. We
observed that mutants for Drosocin alone (DroSK4), or the DiptericinA/B deficiency were not suscep-
tible to this bacterium (Figure 4B). We additionally saw no marked susceptibility of Drosocin-Attacin
A/B-deficient flies, nor Attacin C or Attacin D mutants (not shown). Interestingly, we found that
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compound mutants lacking Drosocin and Attacins A, B, C, and D (Figure 4B: ‘DDro, DAtt’), or Droso-
cin and Diptericins DptA and DptB (‘DDro, DDpt’) displayed an intermediate susceptibility. Only the
Group B mutants lacking Drosocin, all Attacins, and both Diptericins (DDro, DAtt, DDpt) phenocop-
ied DAMPs flies (Figure 4B), with synergistic statistical interactions observed upon co-occurring loss
of Attacins and Diptericins (DAtt*DDpt: HR =+1.45, p<0.001); we emphasize here that this synergis-
tic interaction solely reflects that the effect on survival of combining these mutations is greater than
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Figure 3. Identification of AMPs involved in the susceptibility of DAMPs flies to C. albicans. (A) Survival of mutants for groups of AMPs reveals that loss
of only Toll-responsive Group C peptides (Metchnikowin and Drosomycin) is required to recapitulate the susceptibility of DAMPs flies. Co-occurring loss
of groups A and C has a net protective effect (A*C: HR =  1.71, p=0.002). (B) Further dissection of Group C mutations reveals that both Metchnikowin
and Drosomycin contribute to resist C. albicans survival (p=0.008 and p<0.001, respectively). The interaction of Metchnikowin and Drosomycin was not
different from the sum of their individual effects (Mtk*Drs: HR =  0.80, p=0.116). (C) Fungal loads of individual flies at 18 hpi. At this time point,
BomD55C mutants and spzrm7 flies have already failed to constrain C. albicans growth (C’). Fungal titres at 36hpi (C’’), a time point closer to mortality for
many AMP mutants, show that some AMP mutants fail to control fungal load, while wild-type flies consistently controlled fungal titre. One-way ANOVA:
not significant = ns, p<0.05 = *, p<0.01 = **, and p<0.001 = *** relative to iso w1118.
DOI: https://doi.org/10.7554/eLife.44341.009
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Figure 4. Identification of AMPs involved in the susceptibility of DAMPs flies to P. burhodogranariea. (A) Survival of mutants for groups of AMPs reveals
that loss of Imd-responsive Group B peptides (Drosocin, Attacins, and Diptericins) recapitulates the susceptibility of DAMPs flies. Loss of Group A
peptides also resulted in strong susceptibility (p<0.001) due to additive effects of Defensin and Cecropins (Figure 4—figure supplement 4). (B) Further
dissection of AMPs deleted in Group B reveals that only the loss of all Drosocin, Attacin, and Diptericin gene families leads to susceptibility similar to
DAMPs flies. Simultaneous loss of Attacins and Diptericins results in a synergistic loss of resistance (DAtt*DDpt: HR =+1.45, p<0.001). (C) Bacterial loads
of individual flies at 6 hpi (C’). At this time point, most AMP mutants had significantly higher bacterial loads compared to wild-type flies. At 18 hpi (C’’),
differences in bacterial load are reduced, likely owing to the high chronic load P. burhodogranariea establishes even in surviving flies (Duneau et al.,
2017). Meanwhile RelE20 flies succumb ~18 hr earlier than DAMPs flies in survival experiments, and already have significantly higher loads. One-way
ANOVA: not significant = ns, p<0.05 = *, p<0.01 = **, and p<0.001 = *** relative to iso w1118.
DOI: https://doi.org/10.7554/eLife.44341.010
The following figure supplement is available for figure 4:
Figure supplement 1. Further dissecting effects of AMP groups.
DOI: https://doi.org/10.7554/eLife.44341.011
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the sum effect of the individual mutations (discussed later). By 6hpi, bacterial titres of individual flies
already showed significant differences in the most susceptible genotypes (Figure 4C), although
these differences were reduced by 18 hpi likely owing to the high chronic load P. burhodogranariea
establishes in surviving flies (Duneau et al., 2017; also see Figure 2—figure supplement 1A).
Collectively, the use of various compound mutants reveals that several Imd-responsive AMPs,
notably Drosocin, Attacins, and Diptericins, jointly contribute to defence against P. burhodogranar-
iea infection. A strong susceptibility of Group B flies was also observed upon infection with Ecc15,
another Gram-negative bacterium commonly used to infect flies (Neyen et al., 2014) (Figure 4—fig-
ure supplement 1B ).
Diptericins alone contribute to defence against P. rettgeri
We continued our exploration of AMP interactions using our AMP groups approach with the fairly
virulent P. rettgeri (strain Dmel), a strain isolated from wild-caught Drosophila
hemolymph (Juneja and Lazzaro, 2009). We were especially interested by this bacterium as previ-
ous studies (Unckless et al., 2015; Unckless and Lazzaro, 2016) have shown a correlation between
susceptibility to P. rettgeri and a polymorphism in the Diptericin A gene pointing to a specific AMP-
pathogen interaction. Use of compound mutants revealed only loss of Group B AMPs was needed
to reach the susceptibility of DAMPs and RelE20 flies (Figure 5A). Use of individual mutant lines, how-
ever, revealed a pattern overtly different from P. burhodogranariea, as the sole Diptericin A/B defi-
ciency caused susceptibility similar to Group B, DAMPs, and RelE20 flies (Figure 5B,C). We further
confirmed this susceptibility using a DptA RNAi construct (Figure 5—figure supplement 1A, B).
Moreover, flies carrying the DptSK1 mutation over a deficiency (Df(2R)Exel6067) were also highly sus-
ceptible to P. rettgeri (Figure 5D). Interestingly, flies that were heterozygotes for DptSK1 or the Df
(2R)Exel6067 that still have one copy of the two Diptericins were markedly susceptible to infection
with P. rettgeri (Figure 5D). This indicates that a full transcriptional output of Diptericin is required
over the course of the infection to resist P. rettgeri (Figure 5E). Altogether, our results suggest that
only the Diptericin gene family, amongst the many AMPs regulated by the Imd pathway, provides
the full AMP-based contribution to defence against this bacterium. To test this hypothesis, we gen-
erated a fly line lacking all the AMPs except DptA and DptB (DAMPs+Dpt). Strikingly, DAMPs+Dpt flies
have the same survival rate as wild-type flies, further emphasizing the specificity of this interaction
(Figure 5B). Bacterial counts confirm that the susceptibility of these Diptericin mutants arises from
an inability of the host to suppress bacterial growth (Figure 5C).
Collectively, our study shows that Diptericins are critical to resist P. rettgeri, while they play an
important but less essential role in defence against P. burhodogranariea infection. We were curious
whether Diptericin’s major contribution to defence observed with P. rettgeri could be generalized to
other members of the genus Providencia. An exclusive role for Diptericins was also found for the
more virulent P. stuartii (Figure 5—figure supplement 1C), but not for other Providencia species
tested (P. burhodogranariea, P. alcalifaciens, P. sneebia, P. vermicola) (data not shown).
Drosocin is critical to resist infection with E. cloacae
In the course of our exploration of AMP-pathogen interactions, we identified another highly specific
interaction between E. cloacae and Drosocin. Use of compound mutants revealed that alone, Group
B flies were already susceptible to E. cloacae. Meanwhile, Group AB flies reached DAMPs levels of
susceptibility, while Group A and Group C flies resisted as wild-type (Figure 6A). The high suscepti-
bility of Group AB flies results from a synergistic statistical interaction amongst Group A and Group
B peptides in defence against E. cloacae (A*B, HR =+2.55, p=0.003).
We chose to further explore the AMPs deleted in Group B flies, as alone this genotype already
displayed a strong susceptibility. Use of individual mutant lines revealed that mutants for Drosocin
alone (DroSK4) or the Drosocin-Attacin A/B deficiency (Dro-AttABSK2), but not AttC, AttD, nor DptSK1
(not shown), recapitulate the susceptibility observed in Group B flies (Figure 6B). At 18 hpi, both
DroSK4 and DAMPs flies had significantly higher bacterial loads compared to wild-type flies, while
RelE20 mutants were already moribund with much higher bacterial loads (Figure 6C). Indeed, the
deletion of Drosocin alone alters the fly’s ability to control the otherwise avirulent E. cloacae upon
inoculations using OD = 200 (~39,000 bacteria, Figure 6A–C) or even OD = 10 (~7000 bacteria, Fig-
ure 6—figure supplement 1A).
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Figure 5. Identification of AMPs involved in the susceptibility of DAMPs flies to P. rettgeri. (A) Survival of mutants for groups of AMPs reveals that only
loss of Imd-responsive Group B peptides (Drosocin, Attacins, and Diptericins) recapitulates the susceptibility of DAMPs flies. (B) Further dissection of
the mutations affected in Group B reveals that only the loss of Diptericins (DptSK1) leads to susceptibility similar to DAMPs flies. Remarkably, flies lacking
all other AMPs (DAMPs+Dpt) resist as wild-type. (C) Bacterial loads of individual flies are similar at 6hpi (C’), but by 18hpi (C’’), Dpt mutants and RelE20
flies have all failed to control P. rettgeri growth. (D) Heterozygote flies for DptSK1 and a deficiency including the Diptericins and flanking genes (Df(2R)
Exel6067) recapitulates the susceptibility of Diptericin mutants. Intriguingly, heterozygotes with one functional copy of the Diptericins (+/DptSK1 or +/Df
(2R)Exel6067) are nonetheless highly susceptible to infection. (E) Diptericin A transcriptional output is strongly reduced in heterozygotes 6 hpi
compared to wild-type flies. One-way ANOVA: not significant = ns, p<0.05 = *, p<0.01 = **, and p<0.001 = *** relative to iso w1118.
Figure 5 continued on next page
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We confirmed the high susceptibility of Drosocin mutant flies to E. cloacae in various contexts:
transheterozygote flies carrying DroSK4 over a Drosocin deficiency (Df(2R)BSC858) that also lacks
flanking genes including AttA and AttB ((Figure 6D), the Dro SK4 mutations in an alternate genetic
background (yw, Figure 6E), and, Drosocin RNAi (Figure 6—figure supplement 1B,C). Thus, we
recovered two highly specific AMP-pathogen interactions: Diptericins are essential to combat P.
rettgeri infection, while Drosocin is paramount to surviving E. cloacae infection.
Discussion
A combinatory approach to study AMPs
Despite the recent emphasis on innate immunity, little is known on how immune effectors contribute
individually or collectively to host defence, exemplified by the lack of in depth in vivo functional char-
acterization of Drosophila AMPs. Taking advantage of new gene editing approaches, we developed
a systematic mutation approach to study the function of Drosophila AMPs. With eight distinct muta-
tions, we were able to generate a fly line lacking 14 AMPs that are known to be strongly induced
during the systemic immune response. A striking first finding is that DAMPs flies were perfectly
healthy and have an otherwise wild-type immune response. This indicates that in contrast to
mammals (van Wetering et al., 2002), these Drosophila AMPs are not likely to function as signaling
molecules. Using a systemic mode of infection that induces AMP expression in the fat body and
hemocytes, we found that most flies lacking a single AMP family exhibited a higher susceptibility to
certain pathogens consistent with their in vitro activity. We found activity of Diptericins against P.
rettgeri, Drosocin against E. cloacae, Drosomycin and Metchnikowin against C. albicans, and Defen-
sin and Cecropin against P. burhodogranariea (Figure 4—figure supplement 1A). In most cases, the
susceptibility of single mutants was slight, and the contribution of individual AMPs could be revealed
only when combined to other AMP mutations as illustrated by the susceptibility of Drosocin, Attacin,
and Diptericin combined mutants to P. burhodogranariea. Thus, the use of compound rather than
single mutations provides a better strategy to decipher the contribution of AMPs to host defence.
Our findings are consistent with a previous study using flies that constitutively expressed individual
peptides (Tzou et al., 2002), which showed an activity of Drosomycin against A. fumigatus and Atta-
cin against Ecc15. Beyond the systemic immune response, AMPs are also expressed in many tissues
such as the gut and trachea (Ferrandon et al., 1998; Tzou et al., 2000). Future studies should inves-
tigate the role of AMPs in these local epithelial immune responses.
AMPs and Bomanins are essential contributors to Toll and Imd pathway
mediated host defence
The Toll and Imd pathways provide a paradigm of innate immunity, illustrating how two distinct
pathways link pathogen recognition to distinct but overlapping sets of downstream immune
effectors (Lemaitre and Hoffmann, 2007; Buchon et al., 2014). However, a method of deciphering
the contributions of the different downstream effectors to the specificity of these pathways remained
out of reach, as mutations in these immune effectors were lacking. Our study shows that AMPs con-
tribute greatly to resistance to Gram-negative bacteria. Consistent with this, DAMPs flies are almost
as susceptible as Imd-deficient mutants to most Gram-negative bacteria. In contrast, flies lacking
AMPs were only slightly more susceptible to Gram-positive bacteria and fungal infections compared
to wild-type flies, and this susceptibility rarely approached the susceptibility of Bomanin mutants.
This may be due to the cell walls of Gram-negative bacteria being thinner and more fluid than the
rigid cell walls of Gram-positive bacteria (Fayaz et al., 2010), consequently making Gram-negative
bacteria more prone to the action of pore-forming cationic peptides. It would be interesting to
Figure 5 continued
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The following figure supplement is available for figure 5:
Figure supplement 1. Additional validation of the role of Diptericin in resistance to Providencia.
DOI: https://doi.org/10.7554/eLife.44341.013
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Figure 6. Identification of AMPs involved in the susceptibility of DAMPs flies to E.cloacae. (A) Survival of mutants for groups of AMPs reveals that loss of
Imd-responsive Group B peptides (Drosocin, Attacins, and Diptericins) results in a strong susceptibility to infection (p<0.001), while loss of Group A or C
peptides alone resists as wild-type (p>0.1 each). Group AB flies were as susceptible as DAMPs flies, and we observed a synergistic interaction between
Group A and B mutations (A*B: HR =+2.55, p=0.003). (B) Further dissection of the mutations in Group B revealed that loss of Drosocin alone (DroSK4),
or a deficiency lacking both Drosocin and Attacins AttA and AttB (Dro-AttABSK2) recapitulates the susceptibility of Group B flies. (C) By 18hpi, bacterial
loads in individual Drosocin mutants or RelE20 flies are significantly higher than wild-type. (D) Heterozygote flies for DroSK4 and Df(2R)BSC858 (a
Figure 6 continued on next page
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know if the specificity of AMPs to primarily combatting Gram-negative bacteria is also true in other
species.
Based on our study and Clemmons et al. (2015), we can now explain the susceptibility of Toll
and Imd mutants at the level of the effectors, as we show that mutations affecting Imd-pathway
responsive antibacterial peptide genes are highly susceptible to Gram-negative bacteria while the
Toll-responsive targets Drosomycin, Metchnikowin, and especially the Bomanins, confer resistance
to fungi and Gram-positive bacteria. Thus, the susceptibility of these two pathways to different sets
of microbes not only reflects specificity at the level of recognition, but can now also be translated to
the activities of downstream effectors. It remains to be seen how Bomanins contribute to the micro-
bicidal activity of immune-induced hemolymph, as attempts to synthesize Bomanins have not
revealed direct antimicrobial activity (Lindsay et al., 2018). It should also be noted that many puta-
tive effectors downstream of Toll and Imd remain uncharacterized, and so could also contribute to
host defence beyond these AMPs and Bomanins.
AMPs act additively and synergistically to suppress bacterial growth in
vivo
In the last few years, numerous in vitro studies have focused on the potential for synergistic interac-
tions of AMPs in microbial killing (Rahnamaeian et al., 2015; Yu et al., 2016; Zanchi et al., 2017;
Yan and Hancock, 2001; Nuding et al., 2014; Zerweck et al., 2017; Chen et al., 2005;
Stewart et al., 2014; Zdybicka-Barabas et al., 2012). Our collection of AMP mutant fly lines placed
us in an ideal position to investigate AMP interactions in an in vivo setting. While Toll-responsive
AMPs (Group C: Metchnikowin, Drosomycin) additively contributed to defence against the yeast C.
albicans, we found that certain combinations of AMPs have synergistic contributions to defence
against P. burhodogranariea. Synergistic loss of resistance may arise in two general fashions: first,
co-operation of AMPs using similar mechanisms of action may breach a threshold microbicidal activ-
ity whereupon pathogens are no longer able to resist. This may be the case for the synergistic effect
of Diptericins and Attacins against P. burhodogranariea, as only co-occurring loss of both these
related glycine-rich peptide families (Hedengren et al., 2000) led to complete loss of resistance.
Alternatively, synergy may arise due to complementary mechanisms of action, whereupon one AMP
potentiates the other AMP’s ability to act. For instance, the action of the bumblebee AMP Abaecin,
which binds to the molecular chaperone DnaK to inhibit bacterial DNA replication, is potentiated by
the presence of the pore-forming peptide Hymenoptaecin (Rahnamaeian et al., 2016). Drosophila
Drosocin is highly similar to Abaecin, including O-glycosylation of a critical threonine
residue (Imler and Bulet, 2005; Hanson et al., 2016), and thus likely acts in a similar fashion. Fur-
thermore, Drosophila Attacin C is maturated into both a glycine-rich peptide and a Drosocin-like
peptide called MPAC (Rabel et al., 2004). As such, co-occuring loss of Drosocin, MPAC, and other
possible MPAC-like peptides encoded by the Attacin/Diptericin superfamily may be responsible for
the synergistic loss of resistance in Drosocin, Attacin, Diptericin combined mutants.
AMPs can act with great specificity against certain pathogens
It is commonly thought that the innate immune response lacks the specificity of the adaptive immune
system, which mounts directed defences against specific pathogens. Accordingly for innate immu-
nity, the diversity of immune-inducible AMPs can be justified by the need for generalist and/or co-
operative mechanisms of microbial killing. However, an alternate explanation may be that innate
immunity expresses diverse AMPs in an attempt to hit the pathogen with a ‘silver bullet:’ an AMP
specifically attuned to defend against that pathogen. Here, we provide a demonstration in an in vivo
Figure 6 continued
deficiency removing Drosocin, Attacins AttA and AttB, and other genes) are strongly susceptible to E. cloacae infection. (E) Drosocin mutants in an
alternate genetic background (yw) are susceptible to E. cloacae. One-way ANOVA: not significant = ns, and p<0.001 = *** relative to iso w1118.
DOI: https://doi.org/10.7554/eLife.44341.014
The following figure supplement is available for figure 6:
Figure supplement 1. Additional validation of the role of Drosocin in defence against E. cloacae.
DOI: https://doi.org/10.7554/eLife.44341.015
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setting that such a strategy may actually be employed by the innate immune system. Remarkably,
we recovered not just one, but two examples of exquisite specificity in our laborious but relatively
limited assays.
Diptericin has previously been highlighted for its important role in defence against P.
rettgeri (Unckless et al., 2016), but it was previously unknown whether other AMPs may confer
defence in this infection model. Astoundingly, flies mutant for all other inducible AMPs resisted P.
rettgeri infection as wild-type, while only Diptericin mutants succumbed to infection. This means that
Diptericins do not co-operate with these other AMPs in defence against P. rettgeri and are solely
responsible for defence in this specific host-pathogen interaction. Moreover, +/DptSK1 heterozygote
flies were nonetheless extremely susceptible to infection, demonstrating that a full transcriptional
output over the course of infection is required to effectively prevent pathogen growth. A previous
study has shown that ~7 hpi appears to be the critical time point at which P. rettgeri either grows
unimpeded or the infection is controlled (Duneau et al., 2017). This time point correlates with the
time at which the Diptericin transcriptional output is in full-force (Lemaitre et al., 1997). Thus, a lag
in the transcriptional response in DptSK1/+ flies likely prevents the host from reaching a competent
Diptericin concentration, indicating that Diptericin expression level is a key factor in successful host
defence.
We also show that Drosocin is specifically required for defence against E. cloacae. This striking
finding validates previous biochemical analyses showing Drosocin in vitro activity against several
Enterobacteriaceae, including E. cloacae (Bulet et al., 1996). As DAMPs flies are more susceptible
than Drosocin single mutants, other AMPs also contribute to Drosocin-mediated control of E. cloa-
cae. As highlighted above, Drosocin is similar to other Proline-rich AMPs (e.g. Abaecin, Pyrrhocori-
cin) that have been shown to target bacterial DnaK (Kragol et al., 2001; Rahnamaeian et al., 2015).
Alone, these peptides still penetrate bacteria cell walls through their uptake by bacterial
permeases (Rahnamaeian et al., 2016; Narayanan et al., 2014). Thus, while Drosocin would benefit
from the presence of pore-forming toxins to enter bacterial cells (Rahnamaeian et al., 2016), the
veritable ‘stake to the heart’ is likely the plunging of Drosocin itself into vital bacterial machinery.
On the role of AMPs in host defence
It has often been questioned why flies should need so many AMPs (Lemaitre and Hoffmann, 2007;
Rolff and Schmid-Hempel, 2016; Unckless and Lazzaro, 2016). A common idea, supported by in
vitro experiments (Rahnamaeian et al., 2015; Yan and Hancock, 2001; Zdybicka-Barabas et al.,
2012) is that AMPs work as cocktails, wherein multiple effectors are needed to kill invading patho-
gens. However, we find support for an alternative hypothesis that suggests AMP diversity may be
due to highly specific interactions between AMPs and subsets of pathogens that they target. Bur-
geoning support for this idea also comes from recent evolutionary studies that show Drosophila and
vertebrate AMPs experience positive selection (Unckless et al., 2015; Unckless and Lazzaro, 2016;
Hanson et al., 2016; Chapman et al., 2018; Hellgren and Sheldon, 2011; Tennessen and Blouin,
2008; Sackton, 2019), a hallmark of host-pathogen evolutionary conflict. Our functional demonstra-
tions of AMP-pathogen specificity, using naturally relevant pathogens (Juneja and Lazzaro, 2009;
Cox and Gilmore, 2007), suggest that such specificity is fairly common, and that certain AMPs can
act as the arbiters of life or death upon infection by certain pathogens. This stands in contrast to the
classical view that the AMP response contains such redundancy that single peptides should have lit-
tle effect on organism-level immunity (Rolff and Schmid-Hempel, 2016; Unckless et al., 2015;
Tzou et al., 2000; Unckless and Lazzaro, 2016). Nevertheless, it seems these immune effectors
play non-redundant roles in defence.
By providing a long-awaited in vivo functional validation for the role of AMPs in host defence, we
also pave the way for a better understanding of the functions of immune effectors. Our approach of
using multiple compound mutants, now possible with the development of new genome editing
approaches, was especially effective to decipher the logic of immune effectors. Understanding the
role of AMPs in innate immunity holds great promise for the development of novel
antibiotics (Chung et al., 2017; Mylonakis et al., 2016; Mahlapuu et al., 2016), insight into autoim-
mune diseases (Schluesener et al., 1993; Gilliet and Lande, 2008; Sun et al., 2015; Kumar et al.,
2016), and given their potential for remarkably specific interactions, perhaps in predicting key
parameters that predispose individuals or populations to certain kinds of infections (Unckless et al.,
2015; Unckless and Lazzaro, 2016; Chapman et al., 2018). Finally, our set of isogenized AMP
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mutant lines provides long-awaited tools to decipher the role of AMPs not only in systemic immu-
nity, but also in local immune responses, and the various roles that AMPs may play in aging, neuro-
degeneration, anti-tumor activity, regulation of the microbiota and more, where disparate evidence
has pointed to their involvement.
Materials and methods
Drosophila genetics and mutant generation
The DrosDel (Ryder et al., 2004) isogenic w1118 (iso w1118) wild type was used as a genetic back-
ground for mutant isogenization. Alternate wild-types used throughout include Oregon R (OR-R),
w1118 from the Vienna Drosophila Resource Centre, and the Canton-S isogenic line Exelexis w1118,
which was kindly provided by Brian McCabe. BomD55C mutants were generously provided by Steven
Wasserman, and BomD55C was isogenized into the iso w1118 background. RelE20 and spzrm7 iso w1118
flies were provided by Luis Teixeira (Hedengren et al., 1999; Ferreira et al., 2014). Prophenoloxi-
dase mutants (DPPO) are described in Dudzic et al. (2015). P-element mediated homologous
recombination according to Baena-Lopez et al. (2013) was used to generate mutants for Mtk
(MtkR1) and Drs (DrsR1). Plasmids were provided by Mickael Poidevin. Attacin C mutants (AttCMi,
#25598), the Diptericin deficiency (Df(2R)Exel6067, #7549), the Drosocin deficiency (Df(2R)BSC858,
#27928), UAS-Diptericin RNAi (DptRNAi, #53923), UAS-Drosocin RNAi (DroRNAi, #67223), and
Actin5C-Gal4 (ActGal4, #4414) were ordered from the Bloomington stock centre (stock #s included).
CRISPR mutations were performed by Shu Kondo according to Kondo and Ueda (Kondo and Ueda,
2013), and full descriptions are given in Figure S1. In brief, flies deficient for Drosocin, Attacin A,
and Attacin B (Dro-AttABSK2), Diptericin A and Diptericin B (DptSK1), and Cecropins CecA1, CecA2,
CecB, CecC (CecSK6) were all produced by gene region deletion specific to those AMPs without
affecting other genes. Single mutants for Defensin (DefSK3), Drosocin (DroSK4), and Attacin D
(AttDSK1) are small indels resulting in the production of short (80–107 residues) nonsense peptides.
Mutations were isogenized for a minimum of seven generations into the iso w1118 background prior
to subsequent recombination.
Microbial culture conditions
Bacteria were grown overnight on a shaking plate at 200 rpm in their respective growth media and
temperature conditions, and then pelleted by centrifugation at 4˚C. These bacterial pellets were
diluted to the desired optical density at 600 nm (OD) as indicated. The following bacteria were
grown at 37˚C in LB media: Escherichia coli strain 1106, Salmonella typhimurium, Enterobacter cloa-
cae b12, Providencia rettgeri strain Dmel, Providencia burhodogranariea strain B, Providencia stuartii
strain DSM 4539, Providencia sneebia strain Dmel, Providencia alcalifaciens strain Dmel, Providencia
vermicola strain DSM 17385, Bacillus subtilis, and Staphylococcus aureus. Erwinia carotovora caroto-
vora (Ecc15) and Micrococcus luteus were grown overnight in LB at 29˚C. Enterococcus faecalis and
Listeria innocua were cultured in BHI medium at 37˚C. Candida albicans was cultured in YPG medium
at 37˚C. Aspergillus fumigatus was grown at room temperature on Malt Agar, and spores were col-
lected in sterile PBS rinses, pelleted by centrifugation, and then resuspended to the desired OD in
PBS. The entomopathogenic fungi Beauveria bassiana and Metarhizium anisopliae were grown on
Malt Agar at room temperature until sporulation.
Systemic infections and survival
Systemic infections were performed by pricking 3- to 5-day-old adult males in the thorax with a 100-
mm-thick insect pin dipped into a concentrated pellet of bacteria or fungal spores. Infected flies
were subsequently maintained at 25˚C for experiments. For infections with B. bassiana and M. aniso-
pliae, flies were anesthetized and then shaken on a sporulating plate of fungi for 30 s. At least two
replicate survival experiments were performed for each infection, with 20–35 flies per vial on stan-
dard fly medium without yeast. Survivals were scored twice daily, with additional scoring at sensitive
time points. Comparisons of iso w1118 wild-type to DAMPs mutants were made using a Cox-propor-
tional hazard (CoxPH) model, where independent experiments were included as covariates, and
covariates were removed if not significant (p>0.05). Direct comparisons were performed using Log-
Rank tests in Prism seven software. The effect size and direction is included as the CoxPH hazard
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ratio (HR) where relevant, with a positive effect indicating increased susceptibility. CoxPH models
were used to test for synergistic contributions of AMPs to survival in R 3.4.4. Total sample size (N) is
given for each experiment as indicated.
Quantification of microbial load
The native Drosophila microbiota does not readily grow overnight on LB, allowing for a simple assay
to estimate bacterial load. Flies were infected with bacteria at the indicated OD as described, and
allowed to recover. At the indicated time post-infection, flies were anesthetized using CO2 and sur-
face sterilized by washing them in 70% ethanol. Ethanol was removed, and then flies were homoge-
nized using a Precellys bead beater at 6500 rpm for 30 s in LB broth, with 300 ml for individual
samples, or 500 ml for pools of 5–7 flies. These homogenates were serially diluted and 150 ml was
plated on LB agar. Bacterial plates were incubated overnight, and colony-forming units (CFUs) were
counted manually. Statistical analyses were performed using One-way ANOVA with Sidak’s correc-
tion. p-Values are reported as <0.05 = *,<0.01 = **, and <0.001 = ***. For C. albicans, BiGGY agar
was used instead to select for Candida colonies from fly homogenates.
Gene expression by qPCR
Flies were infected by pricking flies with a needle dipped in a pellet of either E. coli or M. luteus
(OD600 = 200), and frozen at  20˚C 6 hr and 24 hr post-infection, respectively. Total RNA was then
extracted from pooled samples of five flies each using TRIzol reagent, and re-suspended in MilliQ
dH2O. Reverse transcription was performed using 0.5 mg total RNA in 10 ml reactions using Prime-
Script RT (TAKARA) with random hexamer and oligo dT primers. Quantitative PCR was performed
on a LightCycler 480 (Roche) in 96-well plates using Applied Biosystems SYBR Select Master Mix.
Values represent the mean from three replicate experiments. Error bars represent one standard
deviation from the mean. Primers used in this study can be found in Supplementary file 1. Statistical
analyses were performed using one-way ANOVA with Tukey post-hoc comparisons. p-Values are
reported as not significant = ns,<0.05 = *,<0.01 = **, and <0.001 = ***. qPCR primers and
sources (Kounatidis et al., 2017; Hanson et al., 2016; Iatsenko et al., 2016) are included in
Supplementary file 1.
MALDI-TOF peptide analysis
Two methods were used to collect hemolymph from adult flies: in the first method, pools of five
adult females were pricked twice in the thorax and once in the abdomen. Wounded flies were then
spun down with 15 ml of 0.1% trifluoroacetic acid (TFA) at 21000 RCF at 4˚C in a mini-column fitted
with a 10 mm pore to prevent contamination by circulating hemocytes. These samples were frozen at
 20˚C until analysis, and three biological replicates were performed with four technical replicates. In
the second method, approximately 20 nl of fresh hemolymph was extracted from individual adult
males using a Nanoject, and immediately added to 1 ml of 1% TFA, and the matrix was added after
drying. Peptide expression was visualized as described in Uttenweiler-Joseph et al. (1998). Both
methods produced similar results, and representative expression profiles are given.
Melanization and hemocyte characterization, image acquisition
Melanization assays (Dudzic et al., 2018) and peanut agglutinin (PNA) clot staining (Scherfer et al.,
2004) was performed as previously described. In brief, flies or L3 larvae were pricked, and the level
of melanization was assessed at the wound site. We used FACS sorting to count circulating hemo-
cytes. For sessile crystal cell visualization, L3 larvae were cooked in dH2O at 70˚C for 20 min, and
crystal cells were visualized on a Leica DFC300FX camera using Leica Application Suite and counted
manually.
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